United to Cure Cancer (EIN 823796368) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

Matthew Finkelstein

Phone

5058982558

Tax Period

2018-07-01 to 2019-06-30

United to Cure Cancer, founded in 2017, is a micro nonprofit that reported $4K in total revenue in fiscal year 2018. Revenue fell 98% from the prior year — a significant decline worth monitoring. Expenses of $45K exceeded revenue, resulting in a 1020% operating deficit.

Mission

The Corporation is organized exclusively to eradicate cancer. It will facilitate this through, among other things, teaching, raising awareness of available treatments, helpful modalities, how and where to access care, educating about risk factors, screenings, facilitating access to providers, treatments and medicines, supporting research to help eliminate cancer and improve the quality of life of peoples affected by cancer, providing continuing education to the medical community and public.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $4,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $4,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $36,908

Other Expenses $44,790

TOTAL EXPENSES $44,790

Year-over-Year Comparison

	2018	2017	Change
Revenue	$4,000	$200,000	-1.0%
Expenses	$44,790	$7,740	+4.8%
Net Income	$-40,790	$192,260	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Matthew Finkelstein	President	2.00	Officer Director	$0	$0	$0
Alfred L Lopez	Director	0.00	Officer Director	$0	$0	$0
Matthew Rembe	Director	0.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$4,000	$44,790	$157,172	$-40,790

United to Cure Cancer